Drugs in Focus: Octreotide Use in Children With Gastrointestinal Disorders

Area of Science:

• Pediatric Gastroenterology
• Clinical Pharmacology

Background:

• Octreotide, a somatostatin analogue, has a long history of use in pediatric gastrointestinal disorders.
• Established uses include treating bleeding, chylothorax/ascites, lymphangiectasia, pancreatitis, dysmotility, and severe diarrhea.
• A significant gap exists in high-level evidence, specifically randomized clinical trials (RCTs), for its pediatric application.

Purpose of the Study:

• To conduct a literature review to assess the existing evidence on the efficacy and safety of octreotide in children.
• To identify the scope of current research and clinical application of octreotide in pediatric gastrointestinal conditions.

Main Methods:

• A systematic literature search was performed using PubMed.
• The search covered the period from 2000 to 2021.
• Keywords included "octreotide," "children," and specific gastrointestinal conditions such as "bleeding," "chylous ascites," "chylothorax," "acute pancreatitis," "lymphangiectasia," "diarrhea," and "intestinal dysmotility."

Main Results:

• The review synthesizes available data on octreotide's use in pediatric gastrointestinal conditions.
• Evidence regarding efficacy and safety profiles across various indications is evaluated.
• The scarcity of randomized controlled trials is a key finding.

Conclusions:

• Octreotide is frequently utilized in pediatric practice for a range of gastrointestinal issues.
• Further high-quality research, particularly randomized clinical trials, is necessary to definitively establish the efficacy and safety of octreotide in children.
• Current evidence is largely based on observational data and case reports.